These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 28482908)

  • 1. Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial.
    Qian C; Campidelli A; Wang Y; Cai H; Venard V; Jeulin H; Dalle JH; Pochon C; D'aveni M; Bruno B; Paillard C; Vigouroux S; Jubert C; Ceballos P; Marie-Cardine A; Galambrun C; Cholle C; Clerc Urmes I; Petitpain N; De Carvalho Bittencourt M; Decot V; Reppel L; Salmon A; Clement L; Bensoussan D
    J Hematol Oncol; 2017 May; 10(1):102. PubMed ID: 28482908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy.
    Feuchtinger T; Lang P; Hamprecht K; Schumm M; Greil J; Jahn G; Niethammer D; Einsele H
    Exp Hematol; 2004 Mar; 32(3):282-9. PubMed ID: 15003314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus- and cytomegalovirus-specific adoptive T-cell therapy in the context of hematologic cell transplant or HIV infection - A single-center experience.
    Obermaier B; Braun C; Hensen L; Ahmad O; Faul C; Lang P; Bethge W; Lengerke C; Vogel W
    Transpl Infect Dis; 2024 Aug; 26(4):e14296. PubMed ID: 38830809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.
    Lee DA; Denman CJ; Rondon G; Woodworth G; Chen J; Fisher T; Kaur I; Fernandez-Vina M; Cao K; Ciurea S; Shpall EJ; Champlin RE
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1290-1298. PubMed ID: 27090958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter phase 1/2 application of adenovirus-specific T cells in high-risk pediatric patients after allogeneic stem cell transplantation.
    Ip W; Silva JMF; Gaspar H; Mitra A; Patel S; Rao K; Chiesa R; Amrolia P; Gilmour K; Ahsan G; Slatter M; Gennery AR; Wynn RF; Veys P; Qasim W
    Cytotherapy; 2018 Jun; 20(6):830-838. PubMed ID: 29753677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT.
    Neuenhahn M; Albrecht J; Odendahl M; Schlott F; Dössinger G; Schiemann M; Lakshmipathi S; Martin K; Bunjes D; Harsdorf S; Weissinger EM; Menzel H; Verbeek M; Uharek L; Kröger N; Wagner E; Kobbe G; Schroeder T; Schmitt M; Held G; Herr W; Germeroth L; Bonig H; Tonn T; Einsele H; Busch DH; Grigoleit GU
    Leukemia; 2017 Oct; 31(10):2161-2171. PubMed ID: 28090089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Ma CK; Blyth E; Clancy L; Simms R; Burgess J; Brown R; Deo S; Micklethwaite KP; Gottlieb DJ
    Cytotherapy; 2015 Oct; 17(10):1406-20. PubMed ID: 26349000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-γ capture T cell therapy for persistent Adenoviraemia following allogeneic haematopoietic stem cell transplantation.
    Qasim W; Gilmour K; Zhan H; Derniame S; McNicol AM; Ip W; Hiwarkar P; Veys P; Gaspar HB
    Br J Haematol; 2013 May; 161(3):449-52. PubMed ID: 23432400
    [No Abstract]   [Full Text] [Related]  

  • 9. First-in-man clinical results with good manufacturing practice (GMP)-compliant polypeptide-expanded adenovirus-specific T cells after haploidentical hematopoietic stem cell transplantation.
    Geyeregger R; Freimüller C; Stemberger J; Artwohl M; Witt V; Lion T; Fischer G; Lawitschka A; Ritter J; Hummel M; Holter W; Fritsch G; Matthes-Martin S
    J Immunother; 2014 May; 37(4):245-9. PubMed ID: 24714358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfer of Hexon- and Penton-selected adenovirus-specific T cells for refractory adenovirus infection after haploidentical stem cell transplantation.
    Schultze-Florey RE; Tischer-Zimmermann S; Heuft HG; Priesner C; Lamottke B; Heim A; Sauer M; Sykora KW; Blasczyk R; Eiz-Vesper B; Maecker-Kolhoff B
    Transpl Infect Dis; 2020 Feb; 22(1):e13201. PubMed ID: 31643129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-specific T-lymphocyte efficacy in the presence of methylprednisolone: An in vitro study.
    Campidelli A; Qian C; Laroye C; Decot V; Reppel L; D'aveni M; Bensoussan D
    Cytotherapy; 2018 Apr; 20(4):524-531. PubMed ID: 29496461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation.
    Feuchtinger T; Matthes-Martin S; Richard C; Lion T; Fuhrer M; Hamprecht K; Handgretinger R; Peters C; Schuster FR; Beck R; Schumm M; Lotfi R; Jahn G; Lang P
    Br J Haematol; 2006 Jul; 134(1):64-76. PubMed ID: 16803570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation.
    Leen AM; Christin A; Myers GD; Liu H; Cruz CR; Hanley PJ; Kennedy-Nasser AA; Leung KS; Gee AP; Krance RA; Brenner MK; Heslop HE; Rooney CM; Bollard CM
    Blood; 2009 Nov; 114(19):4283-92. PubMed ID: 19700662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation.
    Tzannou I; Papadopoulou A; Naik S; Leung K; Martinez CA; Ramos CA; Carrum G; Sasa G; Lulla P; Watanabe A; Kuvalekar M; Gee AP; Wu MF; Liu H; Grilley BJ; Krance RA; Gottschalk S; Brenner MK; Rooney CM; Heslop HE; Leen AM; Omer B
    J Clin Oncol; 2017 Nov; 35(31):3547-3557. PubMed ID: 28783452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-specific T-cell Subsets in Human Peripheral Blood and After IFN-γ Immunomagnetic Selection.
    Qian C; Wang Y; Cai H; Laroye C; De Carvalho Bittencourt M; Clement L; Stoltz JF; Decot V; Reppel L; Bensoussan D
    J Immunother; 2016 Jan; 39(1):27-35. PubMed ID: 26641259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Experience With CliniMACS Prodigy CCS (IFN-gamma) System in Selection of Virus-specific T Cells From Third-party Donors for Pediatric Patients With Severe Viral Infections After Hematopoietic Stem Cell Transplantation.
    Kállay K; Kassa C; Réti M; Karászi É; Sinkó J; Goda V; Stréhn A; Csordás K; Horváth O; Szederjesi A; Tasnády S; Hardi A; Kriván G
    J Immunother; 2018 Apr; 41(3):158-163. PubMed ID: 29239916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of adenovirus DNA in unrelated donor hematopoietic stem cell transplant recipients.
    Gustafson I; Lindblom A; Yun Z; Omar H; Engstrom L; Lewensohn-Fuchs I; Ljungman P; Broliden K
    J Clin Virol; 2008 Sep; 43(1):79-85. PubMed ID: 18550426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation.
    Hubmann M; Fritsch S; Zoellner AK; Prevalsek D; Engel N; Bücklein V; Mumm F; Schulz C; Stemmler HJ; Jäger G; Ledderose G; Kolb HJ; Hausmann A; Hiddemann W; Moosmann A; Tischer J
    J Clin Virol; 2016 Sep; 82():33-40. PubMed ID: 27428881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Third-Party and Patient-Specific Donor-Derived Virus-Specific T Cells Demonstrate Similar Efficacy and Safety for Management of Viral Infections after Hematopoietic Stem Cell Transplantation in Children and Young Adults.
    Galletta TJ; Lane A; Lutzko C; Leemhuis T; Cancelas JA; Khoury R; Wang YM; Hanley PJ; Keller MD; Bollard CM; Davies SM; Grimley MS; Rubinstein JD
    Transplant Cell Ther; 2023 May; 29(5):305-310. PubMed ID: 36736781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
    Huang X; Liu D
    Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.